MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022
02 August 2022 - 8:00PM
MannKind Corporation (Nasdaq: MNKD) will release
its 2022 second quarter and year to date financial results and its
management will host a conference call to discuss these results and
corporate updates at 5:00 PM (Eastern Time) on Tuesday, August 9,
2022.
Presenting from the Company will be its Chief Executive Officer,
Michael Castagna and Chief Financial Officer, Steven Binder.
Those interested in listening to the conference call live via
the Internet may do so by visiting the Company's website at
https://mannkindcorp.com/news-events/ under Events.
About MannKind CorporationMannKind Corporation
(Nasdaq: MNKD) focuses on the development and commercialization of
innovative therapeutic products and devices to address serious
unmet medical needs for those living with endocrine and orphan lung
diseases. We are committed to helping people manage serious health
conditions – such as diabetes, pulmonary arterial hypertension
(PAH) and idiopathic pulmonary fibrosis (IPF) – and experience life
without limits.
Our approach begins with MannKind’s signature technology
comprised of dry-powder formulation capabilities and inhalation
device engineering that offers rapid and convenient delivery of
medicines to the deep lung where they can exert an effect locally
or enter the systemic circulation.
With a diverse pipeline, and a passionate team of Mannitarians
collaborating nationwide, we are on a mission to give people
control of their health and the freedom to live life.
Please visit mannkindcorp.com to learn more, and follow us on
LinkedIn, Facebook, Twitter or Instagram.
For MannKind: Rose Alinaya,
Investor Relations(818) 661-5000Email: ir@mannkindcorp.com
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Jun 2024 to Jul 2024
MannKind (NASDAQ:MNKD)
Historical Stock Chart
From Jul 2023 to Jul 2024